Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2005
  • Online publication date: August 2009

3 - Transcriptional regulation of labour-associated genes



The clinical onset of labour, characterised by painful uterine contractions leading to cervical dilatation, is a relatively late event in a series of biochemical changes that occur throughout the pregnancy, but particularly in the late third trimester. For most of pregnancy, myometrial contractile activity needs to be repressed, whilst the cervix needs to remain firm and closed to retain the developing fetus within the uterus. Nearer to term, the cervix ripens, a process characterised by dissociation of collagen and a decrease in its concentration and an increase in water content (Osmers et al. 1995). This results in a looser matrix so that cervical tissue offers lower resistance to force and its collagen fibres will deform under tension.

In the myometrium, with the onset of labour, fundally dominant contractions begin. Cervical tissue is drawn up into the lower segment of the uterus, in the processes of effacement and dilatation. Eventually with the establishment of labour, the lower segment itself is drawn up towards the upper segment and the fetus is pushed through the birth canal and into the outside world. These changes within the uterus are associated with changes in the expression of a range of genes that Steven Lye in Toronto has termed ‘contraction-associated proteins’ (CAPs). In the myometrium such proteins include those that form gap junctions (Sparey et al. 1999), proteins in the prostaglandins synthetic pathways (Slater et al. 1999) and receptors for oxytocin (Fuchs et al. 1984) and prostaglandins (Erkinheimo et al. 2000).

Related content

Powered by UNSILO
Adcock, I. M., Nasuhara, Y., Stevens, D. al. (1999) Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. Br. J. Pharmacol. 127, 1003–11.
Aitken, M. A., Rice, G. and Brennecke, S. (1992) Relative abundance of human placental phospholipase A2 messenger RNA in late pregnancy. Prostaglandins 43, 361–70.
Alaoui-El-Azher, M., Wu, Y., Havet, al. (2002) Arachidonic acid differentially affects basal and lipopolysaccharide-induced sPLA(2)-IIA expression in alveolar macrophages through NF-kappaB and PPAR-gamma-dependent pathways. Mol. Pharmacol. 61, 786–94.
Albert, T. J., Su, H. C., Zimmerman, P. al. (1994) Interleukin-1 beta regulates the inducible cyclo-oxygenase in amnion-derived WISH cellsProstaglandins 48, 401–16.
Alfaidy, N., Sun, M., Challis, al. (2003) Expression of membrane prostaglandin E synthase in human placenta and fetal membranes and effect of labour. Endocrine 20, 219–26.
Allport, V. C., Slater, D. M., Newton, al. (2000) NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH)Mol. Hum. Reprod. 6, 561–5.
Allport, V. C., Pieber, D., Slater, D. al. (2001) Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the ‘functional progesterone withdrawal’. Mol. Hum. Reprod. 7, 581–6.
Almawi, W. Y. and Melemedjian, O. K. (2002) Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids. J. Mol. Endocrinol. 28, 69–78.
Alvi, S. A., Brown, N. L., Bennett, P. al. (1999) Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes. Mol. Hum. Reprod. 5, 476–80.
Antonio, V., Brouillet, A., Janvier, al. (2002) Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factors. Biochem. J. 368, 415–24.
Appleby, S. B., Ristimaki, A., Neilson, al. (1994) Structure of the human cyclo-oxygenase-2 gene. Biochem. J. 302 (Pt 3) 723–7.
Auphan, N., DiDonato, J. A., Rosette, al. (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270, 286–90.
Bailey, J., Sparey, C., Phillips, R. al. (2000) Expression of the cyclic AMP-dependent transcription factors, CREB, CREM and ATF2, in the human myometrium during pregnancy and labour. Mol. Hum. Reprod. 6, 648–60.
Bailey, J., Phillips, R. J., Pollard, A. al. (2002) Characterisation and functional analysis of cAMP response element modulator protein and activating transcription factor 2 (ATF2) isoforms in the human myometrium during pregnancy and labour: identification of a novel ATF2 species with potent transactivation properties. J. Clin. Endocrinol. Metab. 87, 1717–28.
Baldwin, A. S. Jr. (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649–83.
Balsinde, J. and Dennis, E. A. (1996) The incorporation of arachidonic acid into triacylglycerol in P388D1 macrophage-like cells. Eur. J. Biochem. 235, 480–5.
Bennett, P., Slater, D., Berger, al. (1994) The expression of phospholipase A2 and lipocortins (annexins) I, II and V in human fetal membranes and placenta in association with labour. Prostaglandins 48, 81–90.
Bennett, W. A., Allbert, J. R., Brackin, M. al. (1999) Secretory component in human amniotic fluid and gestational tissues: a potential endogenous phospholipase A2 inhibitor. J. Soc. Gynecol. Investig. 6, 311–17.
Caivano, M., Gorgoni, B., Cohen, al. (2001) The induction of cyclo-oxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein beta (C/EBP beta) and C/EBP delta transcription factors. J. Biol. Chem. 276, 48693–701.
Calder, A. A. (1997) Review of prostaglandin use in labour induction. BJOG 104 Suppl 15, 2–7; discussion 20–5.
Calder, A. A. and Greer, I. A. (1992) Prostaglandins and the cervix. Baillieres Clin. Obstet. Gynaecol. 6, 771–86.
Challis, J. R., Patel, F. A. and Pomini, F. (1999) Prostaglandin dehydrogenase and the initiation of labour. J. Perinat. Med. 27, 26–34.
Chen, J., Engle, S. J., Seilhamer, J. al. (1994) Cloning and recombinant expression of a novel human low molecular weight Ca(2 +)-dependent phospholipase A2. J. Biol. Chem. 269, 2365–8.
Chwalisz, K., Benson, M., Scholz, al. (1994) Cervical ripening with the cytokines interleukin 8, interleukin 1 beta and tumour necrosis factor alpha in guinea-pigs. Hum. Reprod. 9, 2173–81.
Cicatiello, L., Ambrosino, C., Coletta, al. (1992) Transcriptional activation of jun and actin genes by oestrogen during mitogenic stimulation of rat uterine cells. J. Steroid Biochem. Mol. Biol. 41, 523–8.
Clark, J. D., Lin, L. L., Kriz, R. al. (1991) A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2 +)-dependent translocation domain with homology to PKC and GAP. Cell, 65, 1043–51.
Clark, J. D., Schievella, A. R., Nalefski, E. al. (1995) Cytosolic phospholipase A2. J. Lipid. Mediat. Cell Signal. 12, 83–117.
Couturier, C., Antonio, V., Brouillet, al. (2000) Protein kinase A-dependent stimulation of rat type II secreted phospholipase A(2) gene transcription involves C/EBP-beta and -delta in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 20, 2559–65.
Couturier, C., Brouillet, A., Couriaud, al. (1999) Interleukin 1beta induces type II-secreted phospholipase A(2) gene in vascular smooth muscle cells by a nuclear factor kappaB and peroxisome proliferator-activated receptor-mediated process. J. Biol. Chem. 274, 23085–93.
Crowl, R. M., Stoller, T. J., Conroy, R. al. (1991) Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J. Biol. Chem. 266, 2647–51.
Denison, F. C., Riley, S. C., Elliott, C. al. (2000) The effect of mifepristone administration on leukocyte populations, matrix metalloproteinases and inflammatory mediators in the first trimester cervix. Mol. Hum. Reprod. 6, 541–8.
Desvergne, B. and Wahli, W. (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20, 649–88.
DeWitt, D. L. (1991) Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim. Biophys. Acta 1083, 121–34.
DeWitt, D. L., Meade, E. A. and Smith, W. L. (1993) PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs. Am. J. Med. 95, 40S–44S.
Dolan-O'Keefe, M., Chow, V., Monnier, al. (2000) Transcriptional regulation and structural organization of the human cytosolic phospholipase A(2) gene. Am. J. Physiol. Lung Cell Mol. Physiol. 278, L649–57.
Economopoulos, P., Sun, M., Purgina, al. (1996) Glucocorticoids stimulate prostaglandin H synthase type-2 (PGHS-2) in the fibroblast cells in human amnion cultures. Mol. Cell. Endocrinol. 117, 141–7.
el Maradny, E., Kanayama, N., Halim, al. (1994) Interleukin-8 induces cervical ripening in rabbits. Am. J. Obstet. Gynecol. 171, 77–83.
Elliott, C. L., Kelly, R. W., Critchley, H. al. (1998) Regulation of interleukin 8 production in the term human placenta during labour and by antigestagens. Am. J. Obstet. Gynecol. 179, 215–20.
Elliott, C. L., Slater, D. M., Dennes, al. (2000) Interleukin 8 expression in human myometrium: changes in relation to labour onset and with gestational age. Am. J. Reprod. Immunol. 43, 272–7.
Elliott, C. L., Allport, V. C., Loudon, J. al. (2001a) Nuclear factor-kappa B is essential for upregulation of interleukin-8 expression in human amnion and cervical epithelial cells. Mol. Hum. Reprod. 7, 787–90.
Elliott, C. L., Loudon, J. A., Brown, al. (2001b) IL-1beta and IL-8 in human fetal membranes: changes with gestational age, labour, and culture conditions. Am. J. Reprod. Immunol. 46, 260–7.
Erkinheimo, T. L., Saukkonen, K., Narko, al. (2000) Expression of cyclo-oxygenase-2 and prostanoid receptors by human myometrium. J. Clin. Endocrinol. Metab. 85, 3468–75.
Europe-Finner, G. N., Phaneuf, S., Watson, S. al. (1993) Identification and expression of G-proteins in human myometrium: upregulation of G alpha s in pregnancy. Endocrinology 132, 2484–90.
Europe-Finner, G. N., Phaneuf, S., Tolkovsky, A. al. (1994) Down-regulation of G alpha s in human myometrium in term and preterm labour: a mechanism for parturition. J. Clin. Endocrinol. Metab. 79, 1835–9.
Farrugia, W., Nicholls, L. and Rice, G. E. (1999) Effect of bacterial endotoxin on the in vitro release of Type II phospholipase-A2 and prostaglandin E2 from human placenta. J. Endocrinol. 160, 291–6.
Foster, S. J., Aked, D. M., Schroder, J. al. (1989) Acute inflammatory effects of a monocyte-derived neutrophil-activating peptide in rabbit skin. Immunology 67, 181–3.
Freed, K. A., Moses, E. K., Brennecke, S. al. (1997) Differential expression of type II, IV and cytosolic PLA2 messenger RNA in human intrauterine tissues at term. Mol. Hum. Reprod. 3, 493–9.
Fuchs, A. R., Fuchs, F., Husslein, al. (1984) Oxytocin receptors in the human uterus during pregnancy and parturition. Am. J. Obstet. Gynecol. 150, 734–41.
Gelb, M. H., Valentin, E., Ghomashchi, al. (2000) Cloning and recombinant expression of a structurally novel human secreted phospholipase A2. J. Biol. Chem. 275, 39823–6.
Giannoulias, D., Patel, F. A., Holloway, A. al. (2002) Differential changes in 15-hydroxyprostaglandin dehydrogenase and prostaglandin H synthase (types I and II) in human pregnant myometrium. J. Clin. Endocrinol. Metab. 87, 1345–52.
Gibb, W. and Lavoie, J. C. (1990) Effects of glucocorticoids on prostaglandin formation by human amnion. Can. J. Physiol. Pharmacol. 68, 671–6.
Gorgoni, B., Caivano, M., Arizmendi, al. (2001) The transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts. J. Biol. Chem. 276, 40769–77.
Greenland, K. J., Jantke, I., Jenatschke, al. (2000) The human NAD + -dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone. Endocrinology 141, 581–97.
Harant, H., Martin, R., Andrew, P. al. (1996) Synergistic activation of interleukin-8 gene transcription by all-trans-retinoic acid and tumor necrosis factor-alpha involves the transcription factor NF-kappaB. J. Biol. Chem. 271, 26954–61.
Helmer, H., Tretzmuller, U., Brunbauer, al. (2002) Production of oxytocin receptor and cytokines in primary uterine smooth muscle cells cultivated under inflammatory conditions. J. Soc. Gynecol. Investig. 9, 15–21.
Hirst, J. J., Teixeira, F. J., Zakar, al. (1995) Prostaglandin endoperoxide-H synthase-1 and -2 messenger ribonucleic acid levels in human amnion with spontaneous labour onset. J. Clin. Endocrinol. Metab. 80, 517–23.
Hovland, A. R., Powell, R. L., Takimoto, G. al. (1998) An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J. Biol. Chem. 273, 5455–60.
Inamori, K., Sagawa, N., Hasegawa, al. (1993) Identification and partial characterization of phospholipase D in the human amniotic membrane. Biochem. Biophys. Res. Commun. 191, 1270–7.
Inoue, T., Kimura, T., Azuma, al. (1994) Structural organization of the human oxytocin receptor gene. J. Biol. Chem. 269, 32451–6.
Ishihara, O., Khan, H., Sullivan, M. al. (1992) Interleukin-1 beta stimulates decidual stromal cell cyclo-oxygenase enzyme and prostaglandin production. Prostaglandins 44, 43–52.
Jacques, C., Bereziat, G., Humbert, al. (1997) Posttranscriptional effect of insulin-like growth factor-I on interleukin-1beta-induced type II-secreted phospholipase A2 gene expression in rabbit articular chondrocytes. J. Clin. Invest. 99, 1864–72.
Jakobsson, P. J., Thoren, S., Morgenstern, al. (1999) Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci. U. S. A. 96, 7220–5.
Jobin, c., Hellerbrand, c., Licato, L. L., Brenner, D. A. and Sartor, R. B. (1998) Mediation by NF-KappaB of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors. Gut 42, 779–87.
Johnson, R. F., Mitchell, C. M., Giles, W. al. (2002) The in vivo control of prostaglandin H synthase-2 messenger ribonucleic acid expression in the human amnion at parturition. J. Clin. Endocrinol. Metab. 87, 2816–23.
Junqueira, L. C., Zugaib, M., Montes, G. al. (1980) Morphologic and histochemical evidence for the occurrence of collagenolysis and for the role of neutrophilic polymorphonuclear leukocytes during cervical dilation. Am. J. Obstet. Gynecol. 138, 273–81.
Kalkhoven, E., Wissink, S., Saag, P. al. (1996) Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor. J. Biol. Chem. 271, 6217–24.
Keirse, M. J. and Turnbull, A. C. (1973) E prostaglandins in amniotic fluid during late pregnancy and labour. J. Obstet. Gynaecol. Br. Commonw. 80, 970–3.
Keirse, M. J., Flint, A. P. and Turnbull, A. C. (1974) F prostaglandins in amniotic fluid during pregnancy and labour. J. Obstet. Gynaecol. Br. Commonw. 81, 131–5.
Kilarski, W. M., Hongpaisan, J., Semik, al. (2000) Effect of progesterone and oestradiol on expression of connexin43 in cultured human myometrium cells. Folia. Histochem. Cytobiol. 38, 3–9.
Kimura, T., Takemura, M., Nomura, al. (1996) Expression of oxytocin receptor in human pregnant myometrium. Endocrinology 137, 780–5.
Kirk, R. E., Slater, D. M., Gellerson, al. (2003) Regulation of NAD + -dependent 15-hydroxyprostaglandin dehydrogenase in human term amnion with response to labour. J. Soc. Gynecol. Investig. 10, 145A.
Kudo, I., Murakami, M., Hara, al. (1993) Mammalian non-pancreatic phospholipases A2. Biochim. Biophys. Acta 1170, 217–31.
Kuwata, H., Nakatani, Y., Murakami, al. (1998) Cytosolic phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclo-oxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts. J. Biol. Chem. 273, 1733–40.
Lappas, M., Permezel, M., Georgiou, H. al. (2002) Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-delta(12,14)-PGJ(2) and troglitazone. J. Clin. Endocrinol. Metab. 87, 4667–72.
Lappas, M., Permezel, M., Georgiou, H. al. (2004) Regulation of phospholipase isozymes by nuclear factor-kappaB in human gestational tissues in vitro. J. Clin. Endocrinol. Metab. 89, 2365–72.
Lappas, M., Permezel, M. and Rice, G. E. (2003) N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J. Clin. Endocrinol. Metab. 2003 88, 1723–9.
Lee, Y., Allport, V., Sykes, al. (2003) The effects of labour and of interleukin 1 beta upon the expression of nuclear factor kappa B related proteins in human amnion. Mol. Hum. Reprod. 9, 213–18.
Lim, H., Paria, B. C., Das, S. al. (1997) Multiple female reproductive failures in cyclo-oxygenase 2-deficient mice. Cell 91, 197–208.
Lindstrom, T. L. Y. S., Allport, V. C. and Bennett, P. R. (2002) The pattern of increased NF-kappaB activity in the myometrium in association with labour differs from that stimulated by IL-1beta but both stimulate the COX-2 promoter. J. Soc. Gynecol. Investig. 9, 132A.
Lopez Bernal, A., Anderson, A. B. and Turnbull, A. C. (1982) Cortisol:cortisone interconversion by human decidua in relation to parturition: effect of tissue manipulation on 11 beta-hydroxysteroid dehydrogenase activity. J. Endocrinol. 93, 141–9.
Loudon, J. A., Elliott, C. L., Hills, al. (2003) Progesterone represses interleukin-8 and cyclo-oxygenase-2 in human lower segment fibroblast cells and amnion epithelial cells. Biol. Reprod. 69, 331–7.
Macchia, L., Di Paola, R., Guerrese, M. al. (1997) Expression of prostaglandin endoperoxide H synthase 1 and 2 in human placenta at term. Biochem. Biophys. Res. Commun. 233, 496–501.
Matsuo, M., Ensor, C. M. and Tai, H. H. (1997) Characterization of the genomic structure and promoter of the mouse NAD + -dependent 15-hydroxyprostaglandin dehydrogenase gene. Biochem. Biophys. Res. Commun. 235, 582–6.
Meadows, J. W., Eis, A. L., Brockman, D. al. (2003) Expression and localization of prostaglandin E synthase isoforms in human fetal membranes in term and preterm labour. J. Clin. Endocrinol. Metab. 88, 433–9.
Meis, P. J., Klebanoff, M., Thom, al. (2003) Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N. Engl. J. Med. 348, 2379–85.
Mesiano, S., Chan, E. C., Fitter, J. al. (2002) Progesterone withdrawal and oestrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J. Clin. Endocrinol. Metab. 87, 2924–30.
Mestre, J. R., Rivadeneira, D. E., Mackrell, P. al. (2001) Overlapping CRE and E-box promoter elements can independently regulate COX-2 gene transcription in macrophages. FEBS. Lett. 496, 147–51.
Mitchell, J. A. and Lye, S. J. (2001) Regulation of connexin43 expression by c-fos and c-jun in myometrial cells. Cell. Commun. Adhes. 8, 299–302.
Mitchell, J. A. and Lye, S. J. (2002) Differential expression of activator protein-1 transcription factors in pregnant rat myometrium. Biol. Reprod. 67, 240–6.
Mitchell, B. F. and Olson, D. M. (2004) Prostaglandin endoperoxide H synthase inhibitors and other tocolytics in preterm labour. Prostaglandins Leukot. Essent. Fatty Acids. 70, 167–87.
Mitchell, M. D., Edwin, S. S., Lundin Schiller, al. (1993) Mechanism of interleukin-1 beta stimulation of human amnion prostaglandin biosynthesis: mediation via a novel inducible cyclo-oxygenase. Placenta 14, 615–25.
Molnar, M., Rigo, J., Jr, Romero, al. (1999) Oxytocin activates mitogen-activated protein kinase and up-regulates cyclo-oxygenase-2 and prostaglandin production in human myometrial cells. Am. J. Obstet. Gynecol. 181, 42–9.
Moore, S. D., Brodt-Eppley, J., Cornelison, L. al. (1999) Expression of prostaglandin H synthase isoforms in human myometrium at parturition. Am. J. Obstet. Gynecol. 180, 103–9.
Morishita, M., Miyagi, M. and Iwamoto, Y. (1999) Effects of sex hormones on production of interleukin-1 by human peripheral monocytes. J. Periodontol. 70, 757–60.
Mukaida, N., Morita, M., Ishikawa, al. (1994) Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem. 269, 13289–95.
Munns, M. J., Farrugia, W., King, R. al. (1999) Secretory type II PLA2 immunoreactivity and PLA2 enzymatic activity in human gestational tissues before, during and after spontaneous-onset labour at term. Placenta 20, 21–6.
Murakami, M., Nakatani, Y., Atsumi, al. (1997) Regulatory functions of phospholipase A2. Crit. Rev. Immunol. 17, 225–83.
Murakami, M., Kambe, T., Shimbara, al. (1999a) Functional coupling between various phospholipase A2s and cyclo-oxygenases in immediate and delayed prostanoid biosynthetic pathways. J. Biol. Chem. 274, 3103–15.
Murakami, M., Kambe, T., Shimbara, al. (1999b) Different functional aspects of the group II subfamily (Types IIA and V) and type X secretory phospholipase A(2)s in regulating arachidonic acid release and prostaglandin generation. Implications of cyclo-oxygenase-2 induction and phospholipid scramblase-mediated cellular membrane perturbation. J. Biol. Chem. 274, 31435–44.
Murata, T., Murata, E., Liu, C. al. (2000) Oxytocin receptor gene expression in rat uterus: regulation by ovarian steroids. J. Endocrinol. 166, 45–52.
Naylor, L. H. and Clark, E. M. (1990) d(TG)n.d(CA)n sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription. Nucleic. Acids. Res. 18, 1595–601.
Nguyen, H. T., Rice, G. E., Farrugia, al. (1994) Bacterial endotoxin increases type II phospholipase A2 immunoreactive content and phospholipase A2 enzymatic activity in human choriodecidua. Biol. Reprod. 50, 526–34.
Ohara, O., Ishizaki, J., Nakano, al. (1990) A simple and sensitive method for determining transcription initiation site: identification of two transcription initiation sites in rat group II phospholipase A2 gene. Nucleic Acids Res. 18, 6997–7002.
Okazaki, T., Casey, M. L., Okita, J. al. (1981) Initiation of human parturition. XII. Biosynthesis and metabolism of prostaglandins in human fetal membranes and uterine decidua. Am. J. Obstet. Gynecol. 139, 373–81.
Osman, I., Young, A., Ledingham, M. al. (2003) Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol. Hum. Reprod. 9, 41–5.
Osmers, R., Rath, W., Adelmann-Grill, B. al. (1992) Origin of cervical collagenase during parturition. Am. J. Obstet. Gynecol. 166, 1455–60.
Osmers, R. G., Adelmann-Grill, B. C., Rath, al. (1995) Biochemical events in cervical ripening dilatation during pregnancy and parturition. J. Obstet. Gynaecol. 21, 185–94.
Parry, L. J., Bathgate, R. A., Shaw, al. (1997) Evidence for a local fetal influence on myometrial oxytocin receptors during pregnancy in the tammar wallaby (Macropus eugenii). Biol. Reprod. 56, 200–7.
Patel, F. A., Funder, J. W. and Challis, J. R. (2003) Mechanism of cortisol/progesterone antagonism in the regulation of 15-hydroxyprostaglandin dehydrogenase activity and messenger ribonucleic acid levels in human chorion and placental trophoblast cells at term. J. Clin. Endocrinol. Metab. 88, 2922–33.
Pieber, D., Allport, V. C., Hills, al. (2001) Interactions between progesterone receptor isoforms in myometrial cells in human labour. Mol. Hum. Reprod. 7, 875–9.
Piersanti, M. and Lye, S. J. (1995) Increase in messenger ribonucleic acid encoding the myometrial gap junction protein, connexin-43, requires protein synthesis and is associated with increased expression of the activator protein-1, c-fos. Endocrinology 136, 3571–8.
Pind, S. and Kuksis, A. (1988) Solubilization and assay of phospholipase A2 activity from rat jejunal brush-border membranes. Biochim. Biophys. Acta 938, 211–21.
Pomini, F., Caruso, A. and Challis, J. R. (1999) Interleukin-10 modifies the effects of interleukin-1beta and tumor necrosis factor-alpha on the activity and expression of prostaglandin H synthase-2 and the NAD + -dependent 15-hydroxyprostaglandin dehydrogenase in cultured term human villous trophoblast and chorion trophoblast cells. J. Clin. Endocrinol. Metab. 84, 4645–51.
Potter, S., Mitchell, M. D., Hansen, W. al. (2000) NF-IL6 and CRE elements principally account for both basal and interleukin-1 beta-induced transcriptional activity of the proximal 528bp of the PGHS-2 promoter in amnion-derived AV3 cells: evidence for involvement of C/EBP beta. Mol. Hum. Reprod. 6, 771–8.
Rampart, M., Damme, J., Zonnekeyn, al. (1989) Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am. J. Pathol. 135, 21–5.
Rauk, P. N. and Friebe-Hoffmann, U. (2000) Interleukin-1 beta down-regulates the oxytocin receptor in cultured uterine smooth muscle cells. Am. J. Reprod. Immunol. 43, 85–91.
Rauk, P. N., Friebe-Hoffmann, U., Winebrenner, L. al. (2001) Interleukin-6 up-regulates the oxytocin receptor in cultured uterine smooth muscle cells. Am. J. Reprod. Immunol. 45, 148–53.
Rice, G. E., Wong, M. H., Farrugia, al. (1998) Contribution of type II phospholipase A2 to in vitro phospholipase A2 enzymatic activity in human term placenta. J. Endocrinol. 157, 25–31.
Ricote, M., Li, A. C., Willson, T. al. (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391, 79–82.
Sangha, R. K., Walton, J. C., Ensor, C. al. (1994) Immunohistochemical localization, messenger ribonucleic acid abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labour. J. Clin. Endocrinol. Metab. 78, 982–9.
Satoh, K., Yasumizu, T., Fukuoka, al. (1979) Prostaglandin F2 alpha metabolite levels in plasma, amniotic fluid, and urine during pregnancy and labour. Am. J. Obstet. Gynecol. 133, 886–90.
Schmid, B., Wong, S. and Mitchell, B. F. (2001) Transcriptional regulation of oxytocin receptor by interleukin-1beta and interleukin-6. Endocrinology 142, 1380–5.
Schottelius, A. J., Mayo, M. W., Sartor, R. al. (1999) Interleukin-10 signalling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J. Biol. Chem. 274, 31868–74.
Schuster-Woldan, N., Hilton, M. and Wilson, T. (1997) RU486 inhibits synthesis of an endogenous inhibitor of cell arachidonate release from choriodecidua tissue. Mol. Hum. Reprod. 3, 743–7.
Segain, J. P., Raingeard de la Bletiere, D., Sauzeau, al. (2003) Rho kinase blockade prevents inflammation via nuclear factor kappa B inhibition: evidence in Crohn's disease and experimental colitis. Gastroenterology 124, 1180–7.
Shimonovitz, S., Hurwitz, A., Hochner-Celnikier, al. (1998) Expression of gelatinase B by trophoblast cells: down-regulation by progesterone. Am. J. Obstet. Gynecol. 178, 457–61.
Six, D. A. and Dennis, E. A. (2000) The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim. Biophys. Acta 1488, 1–19.
Skannal, D. G., Brockman, D. E., Eis, A. al. (1997a) Changes in activity of cytosolic phospholipase A2 in human amnion at parturition. Am. J. Obstet. Gynecol. 177, 179–84.
Skannal, D. G., Eis, A. L., Brockman, al. (1997b) Immunohistochemical localization of phospholipase A2 isoforms in human myometrium during pregnancy and parturition. Am. J. Obstet. Gynecol. 176, 878–82.
Skinner, K. A. and Challis, J. R. (1985) Changes in the synthesis and metabolism of prostaglandins by human fetal membranes and decidua at labour. Am. J. Obstet. Gynecol. 151, 519–23.
Slater, D. M., Berger, L. C., Newton, al. (1995) Expression of cyclo-oxygenase types 1 and 2 in human fetal membranes at term. Am. J. Obstet. Gynecol. 172, 77–82.
Slater, D., Allport, V. and Bennett, P. (1998) Changes in the expression of the type-2 but not the type-1 cyclo-oxygenase enzyme in chorio-decidua with the onset of labour. BJOG 105, 745–8.
Slater, D. M., Dennes, W. J., Campa, J. al. (1999) Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy. Mol. Hum. Reprod. 5, 880–4.
Slater, D. M., Myles, L., Sykes, al. (2000) Expression of secretory and cytosolic phospholipase A2 in human myometrium: changes in relation to gestational age and labour onset. J. Soc. Gynecol. Investig. 7, 129A.
Soloff, M. S. (1975) Uterine receptor for oxytocin: effects of oestrogen. Biochem. Biophys. Res. Commun. 65, 205–12.
Soloff, M. S., Fernstrom, M. A., Periyasamy, al. (1983) Regulation of oxytocin receptor concentration in rat uterine explants by oestrogen and progesterone. Can. J. Biochem. Cell Biol. 61, 625–30.
Sooranna, S. R., Lee, Y., Kim, L. al. (2004) Mechanical stretch activates type 2 cyclo-oxygenase via activator protein-1 transcription factor in human myometrial cells. Mol. Hum. Reprod. 10, 109–13.
Sparey, C., Robson, S. C., Bailey, al. (1999) The differential expression of myometrial connexin-43, cyclo-oxygenase-1 and -2, and Gs alpha proteins in the upper and lower segments of the human uterus during pregnancy and labour. J. Clin. Endocrinol. Metab. 84, 1705–10.
Stein, B., Baldwin, A. S. Jr, Ballard, D. al. (1993) Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO. J. 12, 3879–91.
Stuhlmeier, K. M., Kao, J. J. and Bach, F. H. (1997) Arachidonic acid influences proinflammatory gene induction by stabilizing the inhibitor-kappaBalpha/nuclear factor-kappaB (NF-kappaB) complex, thus suppressing the nuclear translocation of NF-kappaB. J. Biol. Chem. 272, 24679–83.
Tanioka, T., Nakatani, Y., Semmyo, al. (2000) Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclo-oxygenase-1 in immediate prostaglandin E2 biosynthesis. J. Biol. Chem. 275, 32775–82.
Tay, A., Maxwell, P., Li, Z. al. (1994) Cytosolic phospholipase A2 gene expression in rat mesangial cells is regulated post-transcriptionally. Biochem. J. 304 (Pt 2), 417–22.
Terzidou, V., Christian, M., Lee, al. (2002) Regulation of Human Oxytocin Receptor by C/EBP and NF-κB. J. Soc. Gynecol. Investig. 9, 90A.
Thomson, A. J., Telfer, J. F., Young, al. (1999) Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum. Reprod. 14, 229–36.
Tomita, N., Morishita, R., Tomita, al. (2000) Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo. Gene. Ther. 7, 1326–32.
Trautman, M. S., Edwin, S. S., Collmer, al. (1996) Prostaglandin H synthase-2 in human gestational tissues: regulation in amnion. Placenta 17, 239–45.
Ueno, N., Murakami, M., Tanioka, al. (2001) Coupling between cyclo-oxygenase, terminal prostanoid synthase, and phospholipase A2. J. Biol. Chem. 276, 34918–27.
Uozumi, N., Kume, K., Nagase, al. (1997) Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 390, 618–22.
Urade, Y., Watanabe, K. and Hayaishi, O. (1995) Prostaglandin D, E, and F synthases. J. Lipid. Mediat. Cell Signal. 12, 257–73.
Meir, C. A., Sangha, R. K., Walton, J. al. (1996) Immunoreactive 15-hydroxyprostaglandin dehydrogenase (PGDH) is reduced in fetal membranes from patients at preterm delivery in the presence of infection. Placenta 17, 291–7.
Meir, C. A., Ramirez, M. M., Matthews, S. al. (1997) Chorionic prostaglandin catabolism is decreased in the lower uterine segment with term labour. Placenta 18, 109–14.
Vane, J. R. and Botting, J. M. (1997) Mechanism of aspirin-like drugs. Semin. Arth. Rheum. 26, 2–10.
Vegeto, E., Shahbaz, M. M., Wen, D. al. (1993) Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol. Endocrinol. 7, 1244–55.
Wang, I. M., Mehta, V. and Cook, R. G. (1993) Regulation of TL antigen expression. Analysis of the T18d promoter region and responses to IFN-gamma. J. Immunol. 151, 2646–57.
Whittle, W. L., Gibb, W. and Challis, J. R. (2000) The characterization of human amnion epithelial and mesenchymal cells: the cellular expression, activity and glucocorticoid regulation of prostaglandin output. Placenta 21, 394–401.
Williams, A. J., Hale, S. L., Moffett, J. al. (2003) Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration. J. Cereb. Blood Flow Metab. 23, 75–87.
Wu, G. D., Lai, E. J., Huang, al. (1997) Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter. The role of Oct-1 as a transcriptional repressor. J. Biol. Chem. 272, 2396–403.
Wu, T., Ikezono, T., Angus, C. al. (1994) Characterization of the promoter for the human 85 kDa cytosolic phospholipase A2 gene. Nucleic Acids Res. 22, 5093–8.
Xue, S., Slater, D. M., Bennett, P. al. (1996) Induction of both cytosolic phospholipase A2 and prostaglandin H synthase-2 by interleukin-1 beta in WISH cells inhibited by dexamethasone. Prostaglandins 51, 107–24.
Yan, X., Sun, M. and Gibb, W. (2002) Localization of nuclear factor-kappa B (NF kappa B) and inhibitory factor-kappa B (I kappa B) in human fetal membranes and decidua at term and preterm delivery. Placenta 23, 288–93.
Young, A., Thomson, A. J., Ledingham, al. (2002) Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term. Biol. Reprod. 66, 445–9.
Zakar, T., Olson, D. M., Teixeira, F. al. (1996) Regulation of prostaglandin endoperoxide H2 synthase in term human gestational tissues. Acta Physiol. Hung. 84, 109–18.
Zuo, J., Lei, Z. M., Rao, C. al. (1994) Differential cyclo-oxygenase-1 and -2 gene expression in human myometria from preterm and term deliveries. J. Clin. Endocrinol. Metab. 79, 894–9.